Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 21.937% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1ccc(S(=O)(=O)CC(=O)c2cc3cccc(C)c3oc2=O)cc1
b.) CCC1C(=O)NCCN1C(=O)CCc1nnc(CCc2ccc(OC)cc2)o1
Answer: b. CCC1C(=O)NCCN1C(=O)CCc1nnc(CCc2ccc(OC)cc2)o1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC1C(=O)NCCN1C(=O)CCc1nnc(CCc2ccc(OC)cc2)o1
CCC1C(=O)NCCN1C(=O)CCc1nnc(CCc2ccc(OC)cc2)o1
3-ethyl-4-[3-[5-[2-(4-methoxyphenyl)ethyl]-1,3,4-oxadiazol-2-yl]propanoyl]piperazin-2-one